Excess O-GlcNAc modification of proteins and myocardial fibrosis
NIH I01BX003230Jan 1, 2018 - Dec 31, 2021
Role: Principal Investigator |
Epicatechin Treatment for Sarcopenia
NIH R56AG052593Sep 30, 2017 - Aug 31, 2019
Role: Principal Investigator |
Epicatechin treatment for sarcopenia
NIH R21AG047326Sep 15, 2015 - Aug 31, 2018
Role: Principal Investigator |
Epicatechin and derivatives to preserve muscle structure function in diabetes
NIH R01DK098717Mar 10, 2014 - Dec 31, 2018
Role: Principal Investigator |
Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin
NIH R01AT008310Sep 1, 2013 - Aug 31, 2016
Role: Principal Investigator |
Targeting cellular bioenergetics for the prevention and treatment of diabetes
NIH R24DK092154Aug 1, 2011 - Jul 31, 2013
Role: Principal Investigator |
Effects of Cocoa Flavonols on Myocardial Infarction Size and Post-Injury Injury
NIH R21AT004277Sep 30, 2008 - Jul 31, 2011
Role: Principal Investigator |
26th Annual Meeting of the North Am. Section of the ISHR
NIH R13HL078318Jul 1, 2004 - Jun 30, 2005
Role: Principal Investigator |
San Diego IRACDA Scholars Program
NIH K12GM068524Aug 1, 2003 - Jun 30, 2026
Role: Principal Investigator |
Adenosine Mediated Modulation of Cardiac Fibrosis
NIH R01HL067922Jul 15, 2002 - Jun 30, 2008
Role: Principal Investigator |
HEART FIBROBLAST AND COLLAGEN TYPE III REGULATION
NIH K14HL003160Jul 1, 1994 - Jun 30, 2000
Role: Principal Investigator |
Molecular biology and mechanics of the cardiac interstitium
NIH R01HL043617Jul 1, 1989 - Mar 31, 2013
Role: Principal Investigator |